U.S. Markets closed

Lonza Group Ltd (LZAGY)

Other OTC - Other OTC Delayed Price. Currency in USD
Add to watchlist
24.12-0.19 (-0.78%)
At close: 3:47PM EDT
People also watch
SONVYKHNGYMKGAYAHEXYJBAXY
Full screen
Previous Close24.31
Open24.26
Bid0.00 x
Ask0.00 x
Day's Range24.07 - 24.26
52 Week Range15.27 - 24.31
Volume9,386
Avg. Volume22,055
Market Cap16.99B
Beta0.97
PE Ratio (TTM)40.50
EPS (TTM)0.6
Earnings DateN/A
Dividend & Yield0.28 (1.22%)
Ex-Dividend Date2017-04-26
1y Target EstN/A
Trade prices are not sourced from all markets
  • Lonza Group AG : Overvalued relative to peers, but good fundamentals
    Capital Cube4 months ago

    Lonza Group AG : Overvalued relative to peers, but good fundamentals

    Categories: Yahoo Finance Lonza Group AG relative valuation is now OVERVALUED. It was previously rated NEUTRAL, and has a fundamental analysis score of 67. Our analysis is based on comparing Lonza Group AG with the following peers – Sarepta Therapeutics, Inc., Amgen Inc., Merrimack Pharmaceuticals, Inc. and Arena Pharmaceuticals, Inc. (SRPT-US, AMGN-US, MACK-US and ARNA-US). Relative Valuation Lonza ... Read more (Read more...)

  • Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended December 31, 2016 : March 6, 2017
    Capital Cube5 months ago

    Lonza Group AG :LZAGY-US: Earnings Analysis: For the six months ended December 31, 2016 : March 6, 2017

    Categories: Yahoo Finance Get free summary analysis Lonza Group AG reports financial results for the half-year ended December 31, 2016. We analyze the earnings along side the following peers of Lonza Group AG – Sarepta Therapeutics, Inc., Amgen Inc. and Merrimack Pharmaceuticals, Inc. (SRPT-US, AMGN-US and MACK-US) that have also reported for this period. Highlights Summary numbers: Revenues ... Read more (Read more...)

  • Reuters6 months ago

    Actelion, Syngenta takeovers set to shake up Swiss SMI index

    The looming foreign takeovers of biotech group Actelion and agrichemicals firm Syngenta look set to trigger the biggest shake-up in the Swiss blue-chip SMI index (.SSMI) in years just as passive investing makes membership increasingly important. Analysts say specialty chemicals group Lonza (LONN.S) may be set to join the Swiss club of the 20 best capitalized and most liquid shares, whose ranks could be thinned even further by the time that the next review takes place in June, analysts say. "It is pretty clear that under the current selection list by the Swiss exchange, Lonza could be taken into the SMI," said Thomas Kuehne, fund manager at Liechtensteinische Landesbank.